nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicotine—CHRNA4—attention deficit hyperactivity disorder	0.391	0.56	CbGaD
Nicotine—MAOA—attention deficit hyperactivity disorder	0.307	0.44	CbGaD
Nicotine—CHAT—locus ceruleus—attention deficit hyperactivity disorder	0.0163	0.151	CbGeAlD
Nicotine—CHAT—autonomic nervous system—attention deficit hyperactivity disorder	0.00867	0.0804	CbGeAlD
Nicotine—MAOA—locus ceruleus—attention deficit hyperactivity disorder	0.0045	0.0417	CbGeAlD
Nicotine—CHRNA4—autonomic nervous system—attention deficit hyperactivity disorder	0.00375	0.0347	CbGeAlD
Nicotine—CHRNB3—forebrain—attention deficit hyperactivity disorder	0.00291	0.027	CbGeAlD
Nicotine—CHRNA6—forebrain—attention deficit hyperactivity disorder	0.00243	0.0226	CbGeAlD
Nicotine—CHAT—forebrain—attention deficit hyperactivity disorder	0.00202	0.0187	CbGeAlD
Nicotine—CHRNB3—midbrain—attention deficit hyperactivity disorder	0.00192	0.0178	CbGeAlD
Nicotine—CHRNA5—nervous system—attention deficit hyperactivity disorder	0.00174	0.0162	CbGeAlD
Nicotine—CHRNA5—central nervous system—attention deficit hyperactivity disorder	0.00168	0.0156	CbGeAlD
Nicotine—CHRNA6—midbrain—attention deficit hyperactivity disorder	0.00161	0.0149	CbGeAlD
Nicotine—CHRNB3—nervous system—attention deficit hyperactivity disorder	0.00158	0.0147	CbGeAlD
Nicotine—CHRNB3—central nervous system—attention deficit hyperactivity disorder	0.00152	0.0141	CbGeAlD
Nicotine—CHRNB3—cerebellum—attention deficit hyperactivity disorder	0.00149	0.0138	CbGeAlD
Nicotine—CHRNB2—forebrain—attention deficit hyperactivity disorder	0.0014	0.013	CbGeAlD
Nicotine—CHRNA3—forebrain—attention deficit hyperactivity disorder	0.00136	0.0126	CbGeAlD
Nicotine—CHAT—midbrain—attention deficit hyperactivity disorder	0.00133	0.0124	CbGeAlD
Nicotine—CHRNA5—brain—attention deficit hyperactivity disorder	0.00133	0.0123	CbGeAlD
Nicotine—CHRNA6—nervous system—attention deficit hyperactivity disorder	0.00132	0.0122	CbGeAlD
Nicotine—CHRNA6—central nervous system—attention deficit hyperactivity disorder	0.00127	0.0118	CbGeAlD
Nicotine—CHRNA2—forebrain—attention deficit hyperactivity disorder	0.00126	0.0117	CbGeAlD
Nicotine—CHRNA6—cerebellum—attention deficit hyperactivity disorder	0.00124	0.0115	CbGeAlD
Nicotine—CHRNB3—brain—attention deficit hyperactivity disorder	0.00121	0.0112	CbGeAlD
Nicotine—CHRNB4—nervous system—attention deficit hyperactivity disorder	0.0012	0.0111	CbGeAlD
Nicotine—CHRNB4—central nervous system—attention deficit hyperactivity disorder	0.00115	0.0107	CbGeAlD
Nicotine—CHAT—nervous system—attention deficit hyperactivity disorder	0.0011	0.0102	CbGeAlD
Nicotine—CHRFAM7A—forebrain—attention deficit hyperactivity disorder	0.0011	0.0102	CbGeAlD
Nicotine—CHAT—central nervous system—attention deficit hyperactivity disorder	0.00106	0.00979	CbGeAlD
Nicotine—CHAT—cerebellum—attention deficit hyperactivity disorder	0.00103	0.00957	CbGeAlD
Nicotine—CHRNA6—brain—attention deficit hyperactivity disorder	0.00101	0.00936	CbGeAlD
Nicotine—CHRNB2—midbrain—attention deficit hyperactivity disorder	0.000923	0.00855	CbGeAlD
Nicotine—CHRNB4—brain—attention deficit hyperactivity disorder	0.000917	0.0085	CbGeAlD
Nicotine—CHRNA7—forebrain—attention deficit hyperactivity disorder	0.000885	0.00821	CbGeAlD
Nicotine—CHRNA4—forebrain—attention deficit hyperactivity disorder	0.000873	0.00809	CbGeAlD
Nicotine—CHAT—brain—attention deficit hyperactivity disorder	0.000838	0.00777	CbGeAlD
Nicotine—CHRNB2—nervous system—attention deficit hyperactivity disorder	0.000759	0.00703	CbGeAlD
Nicotine—CHRNA7—cardiovascular system—attention deficit hyperactivity disorder	0.000748	0.00694	CbGeAlD
Nicotine—CHRNA4—cardiovascular system—attention deficit hyperactivity disorder	0.000738	0.00684	CbGeAlD
Nicotine—SLC22A1—forebrain—attention deficit hyperactivity disorder	0.000738	0.00684	CbGeAlD
Nicotine—CHRNA3—nervous system—attention deficit hyperactivity disorder	0.000736	0.00682	CbGeAlD
Nicotine—CHRNB2—central nervous system—attention deficit hyperactivity disorder	0.00073	0.00677	CbGeAlD
Nicotine—CHRNB2—cerebellum—attention deficit hyperactivity disorder	0.000714	0.00662	CbGeAlD
Nicotine—CHRNA3—central nervous system—attention deficit hyperactivity disorder	0.000708	0.00657	CbGeAlD
Nicotine—CYP19A1—forebrain—attention deficit hyperactivity disorder	0.000694	0.00643	CbGeAlD
Nicotine—CHRNA3—cerebellum—attention deficit hyperactivity disorder	0.000692	0.00642	CbGeAlD
Nicotine—CHRNA2—nervous system—attention deficit hyperactivity disorder	0.000684	0.00634	CbGeAlD
Nicotine—CHRNA2—central nervous system—attention deficit hyperactivity disorder	0.000658	0.0061	CbGeAlD
Nicotine—MAOB—forebrain—attention deficit hyperactivity disorder	0.000653	0.00605	CbGeAlD
Nicotine—CHRNA2—cerebellum—attention deficit hyperactivity disorder	0.000644	0.00597	CbGeAlD
Nicotine—CHRFAM7A—nervous system—attention deficit hyperactivity disorder	0.000595	0.00552	CbGeAlD
Nicotine—CHRNB2—brain—attention deficit hyperactivity disorder	0.00058	0.00537	CbGeAlD
Nicotine—CHRNA4—midbrain—attention deficit hyperactivity disorder	0.000577	0.00535	CbGeAlD
Nicotine—CHRFAM7A—central nervous system—attention deficit hyperactivity disorder	0.000573	0.00531	CbGeAlD
Nicotine—CHRNA3—brain—attention deficit hyperactivity disorder	0.000562	0.00521	CbGeAlD
Nicotine—MAOA—forebrain—attention deficit hyperactivity disorder	0.000557	0.00516	CbGeAlD
Nicotine—MAOB—cardiovascular system—attention deficit hyperactivity disorder	0.000552	0.00512	CbGeAlD
Nicotine—CHRNA2—brain—attention deficit hyperactivity disorder	0.000523	0.00485	CbGeAlD
Nicotine—CHRNA7—nervous system—attention deficit hyperactivity disorder	0.000481	0.00445	CbGeAlD
Nicotine—CHRNA4—nervous system—attention deficit hyperactivity disorder	0.000474	0.00439	CbGeAlD
Nicotine—MAOA—cardiovascular system—attention deficit hyperactivity disorder	0.000471	0.00437	CbGeAlD
Nicotine—CHRNA7—central nervous system—attention deficit hyperactivity disorder	0.000463	0.00429	CbGeAlD
Nicotine—CHRNA4—central nervous system—attention deficit hyperactivity disorder	0.000456	0.00423	CbGeAlD
Nicotine—CHRFAM7A—brain—attention deficit hyperactivity disorder	0.000455	0.00422	CbGeAlD
Nicotine—CYP2A6—cerebellum—attention deficit hyperactivity disorder	0.000452	0.00419	CbGeAlD
Nicotine—CHRNA4—cerebellum—attention deficit hyperactivity disorder	0.000446	0.00414	CbGeAlD
Nicotine—MAOB—midbrain—attention deficit hyperactivity disorder	0.000431	0.004	CbGeAlD
Nicotine—SLC22A1—nervous system—attention deficit hyperactivity disorder	0.000401	0.00371	CbGeAlD
Nicotine—SLC22A4—cerebellum—attention deficit hyperactivity disorder	0.000396	0.00367	CbGeAlD
Nicotine—SLC22A1—central nervous system—attention deficit hyperactivity disorder	0.000386	0.00358	CbGeAlD
Nicotine—SLC22A3—nervous system—attention deficit hyperactivity disorder	0.000383	0.00355	CbGeAlD
Nicotine—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.000377	0.00349	CbGeAlD
Nicotine—CYP19A1—nervous system—attention deficit hyperactivity disorder	0.000376	0.00349	CbGeAlD
Nicotine—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.000373	0.00346	CbGeAlD
Nicotine—SLC22A3—central nervous system—attention deficit hyperactivity disorder	0.000369	0.00342	CbGeAlD
Nicotine—MAOA—midbrain—attention deficit hyperactivity disorder	0.000368	0.00341	CbGeAlD
Nicotine—CHRNA7—brain—attention deficit hyperactivity disorder	0.000367	0.0034	CbGeAlD
Nicotine—CYP2A6—brain—attention deficit hyperactivity disorder	0.000367	0.0034	CbGeAlD
Nicotine—CYP19A1—central nervous system—attention deficit hyperactivity disorder	0.000362	0.00336	CbGeAlD
Nicotine—CHRNA4—brain—attention deficit hyperactivity disorder	0.000362	0.00336	CbGeAlD
Nicotine—MAOB—nervous system—attention deficit hyperactivity disorder	0.000354	0.00328	CbGeAlD
Nicotine—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.000353	0.00328	CbGeAlD
Nicotine—MAOB—central nervous system—attention deficit hyperactivity disorder	0.000341	0.00316	CbGeAlD
Nicotine—SLC22A5—midbrain—attention deficit hyperactivity disorder	0.000339	0.00314	CbGeAlD
Nicotine—MAOB—cerebellum—attention deficit hyperactivity disorder	0.000333	0.00309	CbGeAlD
Nicotine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000331	0.00307	CbGeAlD
Nicotine—SLC22A4—brain—attention deficit hyperactivity disorder	0.000322	0.00298	CbGeAlD
Nicotine—SLC22A1—brain—attention deficit hyperactivity disorder	0.000306	0.00284	CbGeAlD
Nicotine—MAOA—nervous system—attention deficit hyperactivity disorder	0.000302	0.0028	CbGeAlD
Nicotine—SLC22A3—brain—attention deficit hyperactivity disorder	0.000293	0.00271	CbGeAlD
Nicotine—MAOA—central nervous system—attention deficit hyperactivity disorder	0.000291	0.0027	CbGeAlD
Nicotine—CYP19A1—brain—attention deficit hyperactivity disorder	0.000288	0.00267	CbGeAlD
Nicotine—MAOA—cerebellum—attention deficit hyperactivity disorder	0.000284	0.00264	CbGeAlD
Nicotine—MAOB—brain—attention deficit hyperactivity disorder	0.000271	0.00251	CbGeAlD
Nicotine—SLC22A5—cerebellum—attention deficit hyperactivity disorder	0.000262	0.00243	CbGeAlD
Nicotine—CYP1A1—nervous system—attention deficit hyperactivity disorder	0.000249	0.00231	CbGeAlD
Nicotine—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.000242	0.00224	CbGeAlD
Nicotine—CYP1A1—central nervous system—attention deficit hyperactivity disorder	0.00024	0.00222	CbGeAlD
Nicotine—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.000233	0.00216	CbGeAlD
Nicotine—MAOA—brain—attention deficit hyperactivity disorder	0.000231	0.00214	CbGeAlD
Nicotine—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.000227	0.0021	CbGeAlD
Nicotine—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.000218	0.00203	CbGeAlD
Nicotine—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.000214	0.00198	CbGeAlD
Nicotine—SLC22A5—brain—attention deficit hyperactivity disorder	0.000213	0.00197	CbGeAlD
Nicotine—CYP2C8—brain—attention deficit hyperactivity disorder	0.000206	0.00191	CbGeAlD
Nicotine—CYP1A1—brain—attention deficit hyperactivity disorder	0.00019	0.00176	CbGeAlD
Nicotine—CYP2B6—brain—attention deficit hyperactivity disorder	0.000185	0.00171	CbGeAlD
Nicotine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000183	0.00169	CbGeAlD
Nicotine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00018	0.00167	CbGeAlD
Nicotine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000176	0.00163	CbGeAlD
Nicotine—CYP2E1—brain—attention deficit hyperactivity disorder	0.000173	0.00161	CbGeAlD
Nicotine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000173	0.0016	CbGeAlD
Nicotine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000169	0.00157	CbGeAlD
Nicotine—CYP2D6—brain—attention deficit hyperactivity disorder	0.000137	0.00127	CbGeAlD
Nicotine—MAOA—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	5.16e-05	0.000265	CbGpPWpGaD
Nicotine—CHRNA7—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	4.99e-05	0.000256	CbGpPWpGaD
Nicotine—SLC22A1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	4.84e-05	0.000249	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—TPH2—attention deficit hyperactivity disorder	4.82e-05	0.000247	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.82e-05	0.000247	CbGpPWpGaD
Nicotine—SLC22A2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	4.81e-05	0.000247	CbGpPWpGaD
Nicotine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	4.8e-05	0.000246	CbGpPWpGaD
Nicotine—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	4.76e-05	0.000244	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—DPYD—attention deficit hyperactivity disorder	4.74e-05	0.000243	CbGpPWpGaD
Nicotine—MAOA—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	4.71e-05	0.000242	CbGpPWpGaD
Nicotine—CYP2A6—Biological oxidations—COMT—attention deficit hyperactivity disorder	4.58e-05	0.000235	CbGpPWpGaD
Nicotine—CYP2A6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	4.54e-05	0.000233	CbGpPWpGaD
Nicotine—CHAT—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.53e-05	0.000233	CbGpPWpGaD
Nicotine—SLC22A4—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.53e-05	0.000232	CbGpPWpGaD
Nicotine—SLC22A1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	4.48e-05	0.00023	CbGpPWpGaD
Nicotine—SLC22A2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	4.47e-05	0.000229	CbGpPWpGaD
Nicotine—SLC22A2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	4.42e-05	0.000227	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.4e-05	0.000226	CbGpPWpGaD
Nicotine—SLC22A2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	4.39e-05	0.000225	CbGpPWpGaD
Nicotine—CHAT—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.31e-05	0.000221	CbGpPWpGaD
Nicotine—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	4.21e-05	0.000216	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	4.2e-05	0.000216	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	4.2e-05	0.000216	CbGpPWpGaD
Nicotine—SLC22A1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	4.16e-05	0.000214	CbGpPWpGaD
Nicotine—SLC22A1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	4.12e-05	0.000211	CbGpPWpGaD
Nicotine—SLC22A1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	4.09e-05	0.00021	CbGpPWpGaD
Nicotine—CHRNA4—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	4.07e-05	0.000209	CbGpPWpGaD
Nicotine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	4.06e-05	0.000209	CbGpPWpGaD
Nicotine—MAOA—Neuronal System—COMT—attention deficit hyperactivity disorder	4e-05	0.000206	CbGpPWpGaD
Nicotine—SLC22A2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	3.98e-05	0.000204	CbGpPWpGaD
Nicotine—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	3.93e-05	0.000202	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.85e-05	0.000198	CbGpPWpGaD
Nicotine—MAOB—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.84e-05	0.000197	CbGpPWpGaD
Nicotine—CYP1A2—Phase II conjugation—COMT—attention deficit hyperactivity disorder	3.72e-05	0.000191	CbGpPWpGaD
Nicotine—SLC22A1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	3.71e-05	0.000191	CbGpPWpGaD
Nicotine—CYP2B6—Biological oxidations—COMT—attention deficit hyperactivity disorder	3.69e-05	0.00019	CbGpPWpGaD
Nicotine—CYP2B6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	3.67e-05	0.000188	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.67e-05	0.000188	CbGpPWpGaD
Nicotine—CYP2B6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	3.64e-05	0.000187	CbGpPWpGaD
Nicotine—CYP2E1—Biological oxidations—COMT—attention deficit hyperactivity disorder	3.62e-05	0.000186	CbGpPWpGaD
Nicotine—CYP2E1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	3.59e-05	0.000184	CbGpPWpGaD
Nicotine—CYP2E1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	3.57e-05	0.000183	CbGpPWpGaD
Nicotine—CHAT—Metabolism—COMT—attention deficit hyperactivity disorder	3.43e-05	0.000176	CbGpPWpGaD
Nicotine—SLC22A3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	3.41e-05	0.000175	CbGpPWpGaD
Nicotine—CYP1A1—Biological oxidations—COMT—attention deficit hyperactivity disorder	3.41e-05	0.000175	CbGpPWpGaD
Nicotine—CHAT—Metabolism—MAOA—attention deficit hyperactivity disorder	3.41e-05	0.000175	CbGpPWpGaD
Nicotine—SLC22A5—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	3.4e-05	0.000175	CbGpPWpGaD
Nicotine—CYP1A1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	3.39e-05	0.000174	CbGpPWpGaD
Nicotine—SLC22A2—Neuronal System—COMT—attention deficit hyperactivity disorder	3.39e-05	0.000174	CbGpPWpGaD
Nicotine—CYP1A1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	3.36e-05	0.000173	CbGpPWpGaD
Nicotine—SLC22A2—Neuronal System—MAOA—attention deficit hyperactivity disorder	3.36e-05	0.000173	CbGpPWpGaD
Nicotine—CHAT—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	3.3e-05	0.00017	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.25e-05	0.000167	CbGpPWpGaD
Nicotine—SLC22A1—Neuronal System—COMT—attention deficit hyperactivity disorder	3.16e-05	0.000162	CbGpPWpGaD
Nicotine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	3.14e-05	0.000161	CbGpPWpGaD
Nicotine—SLC22A1—Neuronal System—MAOA—attention deficit hyperactivity disorder	3.13e-05	0.000161	CbGpPWpGaD
Nicotine—CYP2C8—Biological oxidations—COMT—attention deficit hyperactivity disorder	3.13e-05	0.000161	CbGpPWpGaD
Nicotine—CYP2C8—Biological oxidations—MAOA—attention deficit hyperactivity disorder	3.1e-05	0.000159	CbGpPWpGaD
Nicotine—CYP2C8—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	3.08e-05	0.000158	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—COMT—attention deficit hyperactivity disorder	2.92e-05	0.00015	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—MAOA—attention deficit hyperactivity disorder	2.9e-05	0.000149	CbGpPWpGaD
Nicotine—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	2.79e-05	0.000143	CbGpPWpGaD
Nicotine—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	2.77e-05	0.000142	CbGpPWpGaD
Nicotine—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	2.75e-05	0.000141	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—EP300—attention deficit hyperactivity disorder	2.74e-05	0.000141	CbGpPWpGaD
Nicotine—MAOA—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	2.73e-05	0.00014	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	2.68e-05	0.000138	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	2.68e-05	0.000138	CbGpPWpGaD
Nicotine—MAOB—Metabolism—TPH2—attention deficit hyperactivity disorder	2.65e-05	0.000136	CbGpPWpGaD
Nicotine—MAOB—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.65e-05	0.000136	CbGpPWpGaD
Nicotine—MAOB—Metabolism—DPYD—attention deficit hyperactivity disorder	2.61e-05	0.000134	CbGpPWpGaD
Nicotine—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	2.57e-05	0.000132	CbGpPWpGaD
Nicotine—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	2.55e-05	0.000131	CbGpPWpGaD
Nicotine—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	2.54e-05	0.000131	CbGpPWpGaD
Nicotine—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	2.53e-05	0.00013	CbGpPWpGaD
Nicotine—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	2.53e-05	0.00013	CbGpPWpGaD
Nicotine—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	2.51e-05	0.000129	CbGpPWpGaD
Nicotine—MAOB—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.43e-05	0.000125	CbGpPWpGaD
Nicotine—MAOA—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.41e-05	0.000124	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.35e-05	0.000121	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—TPH2—attention deficit hyperactivity disorder	2.24e-05	0.000115	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.24e-05	0.000115	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—DPYD—attention deficit hyperactivity disorder	2.21e-05	0.000113	CbGpPWpGaD
Nicotine—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	2.17e-05	0.000112	CbGpPWpGaD
Nicotine—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	2.16e-05	0.000111	CbGpPWpGaD
Nicotine—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	2.14e-05	0.00011	CbGpPWpGaD
Nicotine—SLC22A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	2.14e-05	0.00011	CbGpPWpGaD
Nicotine—MAOB—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.12e-05	0.000109	CbGpPWpGaD
Nicotine—CYP1A1—PPARA activates gene expression—EP300—attention deficit hyperactivity disorder	2.09e-05	0.000107	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.05e-05	0.000105	CbGpPWpGaD
Nicotine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—attention deficit hyperactivity disorder	2.05e-05	0.000105	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.04e-05	0.000105	CbGpPWpGaD
Nicotine—MAOB—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.02e-05	0.000104	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	2e-05	0.000102	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.9e-05	9.76e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.87e-05	9.61e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.79e-05	9.21e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.71e-05	8.77e-05	CbGpPWpGaD
Nicotine—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	1.68e-05	8.62e-05	CbGpPWpGaD
Nicotine—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	1.67e-05	8.56e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—TPH2—attention deficit hyperactivity disorder	1.66e-05	8.54e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.66e-05	8.54e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	1.65e-05	8.5e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—DPYD—attention deficit hyperactivity disorder	1.64e-05	8.41e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—TPH2—attention deficit hyperactivity disorder	1.62e-05	8.33e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.62e-05	8.33e-05	CbGpPWpGaD
Nicotine—MAOB—Metabolism—COMT—attention deficit hyperactivity disorder	1.61e-05	8.25e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—DPYD—attention deficit hyperactivity disorder	1.6e-05	8.2e-05	CbGpPWpGaD
Nicotine—MAOB—Metabolism—MAOA—attention deficit hyperactivity disorder	1.6e-05	8.19e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.52e-05	7.81e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.51e-05	7.75e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.48e-05	7.62e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.48e-05	7.59e-05	CbGpPWpGaD
Nicotine—CHAT—Metabolism—EP300—attention deficit hyperactivity disorder	1.47e-05	7.56e-05	CbGpPWpGaD
Nicotine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	1.41e-05	7.24e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—TPH2—attention deficit hyperactivity disorder	1.41e-05	7.23e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.41e-05	7.23e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.39e-05	7.16e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—DPYD—attention deficit hyperactivity disorder	1.38e-05	7.11e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—COMT—attention deficit hyperactivity disorder	1.36e-05	6.98e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—MAOA—attention deficit hyperactivity disorder	1.35e-05	6.93e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.33e-05	6.83e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—TPH2—attention deficit hyperactivity disorder	1.31e-05	6.74e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.31e-05	6.74e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.3e-05	6.66e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—TPH2—attention deficit hyperactivity disorder	1.29e-05	6.63e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.29e-05	6.63e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—DPYD—attention deficit hyperactivity disorder	1.29e-05	6.63e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.29e-05	6.61e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.28e-05	6.56e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—DPYD—attention deficit hyperactivity disorder	1.27e-05	6.53e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.27e-05	6.5e-05	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—EP300—attention deficit hyperactivity disorder	1.25e-05	6.43e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.24e-05	6.34e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.2e-05	6.16e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.18e-05	6.07e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.14e-05	5.86e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.13e-05	5.78e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.07e-05	5.5e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.05e-05	5.39e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.05e-05	5.38e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	1.04e-05	5.35e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.04e-05	5.35e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.04e-05	5.34e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.03e-05	5.3e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	1.03e-05	5.27e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—TPH2—attention deficit hyperactivity disorder	1.02e-05	5.24e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.02e-05	5.24e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—COMT—attention deficit hyperactivity disorder	1.01e-05	5.18e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—DPYD—attention deficit hyperactivity disorder	1e-05	5.16e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.98e-06	5.13e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—COMT—attention deficit hyperactivity disorder	9.83e-06	5.05e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.83e-06	5.05e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—MAOA—attention deficit hyperactivity disorder	9.76e-06	5.01e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.63e-06	4.94e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	9.63e-06	4.94e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.53e-06	4.9e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	9.47e-06	4.86e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	9.47e-06	4.86e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.34e-06	4.79e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	8.89e-06	4.57e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	8.82e-06	4.53e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.82e-06	4.53e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.8e-06	4.52e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	8.68e-06	4.46e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—COMT—attention deficit hyperactivity disorder	8.53e-06	4.38e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—MAOA—attention deficit hyperactivity disorder	8.47e-06	4.35e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.33e-06	4.28e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.16e-06	4.19e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.07e-06	4.14e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—COMT—attention deficit hyperactivity disorder	7.95e-06	4.08e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.93e-06	4.07e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—MAOA—attention deficit hyperactivity disorder	7.89e-06	4.05e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	7.88e-06	4.04e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.88e-06	4.04e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—COMT—attention deficit hyperactivity disorder	7.83e-06	4.02e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—MAOA—attention deficit hyperactivity disorder	7.77e-06	3.99e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.77e-06	3.99e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	7.75e-06	3.98e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.69e-06	3.95e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.33e-06	3.76e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	7.24e-06	3.72e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.24e-06	3.72e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.2e-06	3.7e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	7.18e-06	3.69e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.18e-06	3.69e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	7.13e-06	3.66e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	7.07e-06	3.63e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.05e-06	3.62e-05	CbGpPWpGaD
Nicotine—MAOB—Metabolism—EP300—attention deficit hyperactivity disorder	6.89e-06	3.54e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	6.86e-06	3.52e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.72e-06	3.45e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.63e-06	3.4e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.57e-06	3.37e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	6.32e-06	3.24e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.3e-06	3.23e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	6.27e-06	3.22e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	6.19e-06	3.18e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	6.14e-06	3.15e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	6.14e-06	3.15e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	6.14e-06	3.15e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	6.04e-06	3.1e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.99e-06	3.08e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—COMT—attention deficit hyperactivity disorder	5.83e-06	2.99e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—EP300—attention deficit hyperactivity disorder	5.83e-06	2.99e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.79e-06	2.97e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	5.79e-06	2.97e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.74e-06	2.95e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	5.62e-06	2.88e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.61e-06	2.88e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.51e-06	2.83e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.47e-06	2.81e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	5.35e-06	2.75e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	5.31e-06	2.73e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	5.15e-06	2.64e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.91e-06	2.52e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	4.77e-06	2.45e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	4.74e-06	2.43e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	4.74e-06	2.43e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.74e-06	2.43e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.67e-06	2.4e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	4.66e-06	2.39e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	4.6e-06	2.36e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	4.39e-06	2.25e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	4.36e-06	2.24e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	4.35e-06	2.23e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.33e-06	2.22e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—EP300—attention deficit hyperactivity disorder	4.32e-06	2.22e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	4.32e-06	2.22e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—EP300—attention deficit hyperactivity disorder	4.22e-06	2.17e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	4.19e-06	2.15e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.79e-06	1.94e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	3.72e-06	1.91e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	3.69e-06	1.9e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—EP300—attention deficit hyperactivity disorder	3.66e-06	1.88e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.6e-06	1.85e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	3.58e-06	1.84e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—EP300—attention deficit hyperactivity disorder	3.41e-06	1.75e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—EP300—attention deficit hyperactivity disorder	3.36e-06	1.72e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	2.87e-06	1.47e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	2.85e-06	1.46e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	2.71e-06	1.39e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	2.65e-06	1.36e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—EP300—attention deficit hyperactivity disorder	2.5e-06	1.28e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	2.29e-06	1.18e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	2.05e-06	1.05e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	1.88e-06	9.67e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	1.87e-06	9.58e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	1.59e-06	8.19e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.23e-06	6.32e-06	CbGpPWpGaD
